Anúncio
Anúncio
ATYR
aTyr Pharma, Inc. Common Stock
0.71
USDPatrocinado
-0.01
-1.67%
09 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
0.72
+0.01
+1.02%
Relatórios de Lucros ATYR
Rácio de surpresa positiva
ATYR separação 28 de 40 últimas estimativas.
70%
Próximo Relatório
Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$34.00K
/-$0.19
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-82.11%
/-26.92%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+5.56%
aTyr Pharma, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, ATYR reported earnings of -0.26 USD per share (EPS) for Q3 25, missing the estimate of -0.18 USD, resulting in a -38.81% surprise. Revenue reached 190.00 mil, compared to an expected 1.36 milhão, with a -86.03% difference. The market reacted with a +6.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -0.19 USD, with revenue projected to reach 34.00 mil USD, implying an diminuir of -26.92% EPS, and diminuir of -82.11% in Revenue from the last quarter.
FAQ
What were aTyr Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, aTyr Pharma, Inc. Common Stock reported EPS of -$0.26, missing estimates by -38.81%, and revenue of $190.00K, -86.03% below expectations.
How did the market react to aTyr Pharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 6.05%, changed from $0.77 before the earnings release to $0.82 the day after.
When is aTyr Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for aTyr Pharma, Inc. Common Stock's next earnings report?
Based on 12
analistas, aTyr Pharma, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of $34.00K for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio